Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 03:06 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Obesity Study to Assess Induction of Labor
NCT03796416 · University of Maryland, Baltimore · NA · withdrawn · last registry update 2022-03-22 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “in error” | – | Registry record, University of Maryland, Baltimore |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGER3 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-03-17Phase 3 first posted: Hospital Universitario 12 de Octubre, Vaginal dinoprostone (NCT05774236)
- 2023-03-09Phase 3 first posted: Beni-Suef University, Dinoprostone + Misoprostol (NCT05761418)
- 2023-01-23Results posted on the registry: Boston Medical Center, Methadone Pill + Ibuprofen (NCT04941443)
- 2023-01-23Also stopped (terminated): Boston Medical Center, Methadone Pill + Ibuprofen (NCT04941443)
- 2022-11-30Results posted on the registry: Vanderbilt University Medical Center, Misoprostol 100Mcg Tab (NCT03617172)
- 2022-11-30Also stopped (terminated): Vanderbilt University Medical Center, Misoprostol 100Mcg Tab (NCT03617172)
- 2022-11-14Also stopped (terminated): South Warwickshire NHS Foundation Trust, 10 mg Dinoprostone; CTS, UK + 3 mg Dinoprostone vaginal tablet; Pfizer, UK (NCT02956785)
- 2022-10-13Results posted on the registry: Milton S. Hershey Medical Center, Misoprostol (NCT02777190)
- 2022-10-13Also stopped (terminated): Milton S. Hershey Medical Center, Misoprostol (NCT02777190)
- 2022-06-21Phase 3 first posted: Karolinska Institutet, Misoprostol (NCT05424445)
- 2022-03-31Phase 3 first posted: Calcutta National Medical College and Hospital, Mifepristone + Letrozole (NCT05304273)
- 2022-03-02Results posted on the registry: Medstar Health Research Institute, Mifepristone + Misoprostol (NCT02412618)
- 2022-02-17Phase 3 first posted: Stony Brook University, Sublingual Misoprostol + IV Oxytocin (NCT05245227)
- 2021-11-05Phase 3 first posted: Pak Emirates Military Hospital, Misoprostol (NCT05108597)
- 2021-11-01Results posted on the registry: Yuzuncu Yil University, Chlorhexidine Gluconate 0.12 % Mouthwash + benzydamine hydrochloride (NCT04373421)
- 2021-10-28Phase 3 first posted: Stanford University, Mifepristone + Misoprostol (NCT05097326)
- 2021-09-30Results posted on the registry: New York City Health and Hospitals Corporation, misoprostol (NCT02411916)
- 2021-09-05Results posted on the registry: Intermountain Health Care, Inc., Outpatient Dinoprostone 10mg + Inpatient Dinoprostone 10 mg (NCT03806231)
- 2021-09-05Also stopped (terminated): Intermountain Health Care, Inc., Outpatient Dinoprostone 10mg + Inpatient Dinoprostone 10 mg (NCT03806231)
- 2021-08-10Results posted on the registry: Montefiore Medical Center, Misoprostol + Oxytocin (NCT02314728)
- 2021-07-26Also stopped (terminated): Gynuity Health Projects, Mifepristone + Misoprostol (NCT02704481)
- 2021-07-23Also stopped (terminated): Gynuity Health Projects, Mifepristone + Misoprostol (NCT04063904)
- 2021-07-12Results posted on the registry: Daniel Grossman, Mifepristone (NCT03320057)
- 2021-07-09Results posted on the registry: Montefiore Medical Center, Misoprostol (NCT02680314)
- 2021-07-02Phase 3 first posted: University Hospital, Tours, Prostaglandins + Oxytocin (NCT04949633)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision